Clinical Trial Update: CYP19A1 (Cytochrome P450 Family 19 Subfamily A Member 1) Gene and Pharmacogenetics of Response to Testosterone Therapy [Phase 1]

View source ↗

Summary

Phase 1 trial exploring CYP19A1 gene pharmacogenetics and response to testosterone therapy in hypogonadism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogonadism

Snippet

Sponsor: VA Office of Research and Development | Conditions: Hypogonadism | Phase 1 | Status: COMPLETED | Results posted: 2019-03-05